Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-10

Clinical Trial Update: A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the addition of atorvastatin to endocrine therapy for advanced breast cancer; the study focuses on resistance mechanisms to Fu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atorvastatin (atorvastatin)

Snippet

Sponsor: Lund University Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED